Contrave vs. GLP-1 Medications: Which Weight Loss Medication Is Right for You?

GLP-1 medications get most of the attention in weight loss conversations. But they're not the only option — and they're not the right fit for everyone. Contrave, a combination of naltrexone and bupropion, has been quietly effective for certain patients since its FDA approval in 2014.

Understanding how these medications compare — mechanism, efficacy, side effects, cost, and ideal patient profile — helps you and your provider choose the approach most likely to work for your situation.

How Contrave Works

Contrave combines two medications that were each originally developed for something else entirely:

Bupropion was developed as an antidepressant (Wellbutrin) and later approved for smoking cessation (Zyban). It works primarily on norepinephrine and dopamine pathways in the brain — the same pathways involved in motivation, reward, and appetite regulation.

Naltrexone is an opioid receptor antagonist originally used to treat opioid and alcohol dependence. In the brain, naltrexone blocks endogenous opioid signaling, which plays a role in the pleasure and reward aspects of eating.

Together, they work synergistically on the hypothalamic appetite regulation center:

• Bupropion stimulates POMC neurons (pro-opiomelanocortin), which produce signals that reduce appetite
• POMC neurons normally self-regulate through an opioid feedback loop that limits their activity
• Naltrexone blocks this feedback loop, allowing sustained POMC activation
• The result is prolonged appetite suppression that neither drug achieves alone

This is a fundamentally different mechanism from GLP-1 medications, which work through incretin hormone pathways, gastric emptying, and distinct brain receptor systems.

Head-to-Head: The Numbers

Weight Loss Efficacy

Contrave:

• Average weight loss in clinical trials: 5-8% of body weight at 56 weeks
• Percentage of patients losing at least 5%: approximately 42-55%
• Percentage of patients losing at least 10%: approximately 20-30%

Semaglutide 2.4 mg (Wegovy):

• Average weight loss: 15-17% of body weight at 68 weeks
• Percentage of patients losing at least 5%: approximately 83-86%
• Percentage of patients losing at least 10%: approximately 66-69%

Tirzepatide 15 mg (Zepbound):

• Average weight loss: 20-22% of body weight at 72 weeks
• Percentage of patients losing at least 5%: approximately 91%
• Percentage of patients losing at least 10%: approximately 79%

The weight loss gap is significant. GLP-1 medications produce roughly 2-3 times more weight loss than Contrave on average. If maximum weight loss is the primary goal and all options are equally accessible, GLP-1 medications are the stronger choice.

But efficacy isn't the only consideration.

Side Effect Profiles

Contrave common side effects:

• Nausea (32%) — the most common, usually decreasing over time
• Constipation (19%)
• Headache (18%)
• Vomiting (10%)
• Dizziness (10%)
• Insomnia (9%)
• Dry mouth (8%)
• Diarrhea (7%)

GLP-1 common side effects:

• Nausea (20-44%)
• Diarrhea (15-30%)
• Constipation (10-25%)
• Vomiting (10-24%)
• Injection site reactions (3-7%)
• Potential for pancreatitis (rare)
• Gallbladder events (rare)

Both medication classes cause significant GI side effects, particularly nausea. The side effect profiles are different in character though — Contrave adds CNS effects (headache, insomnia, dizziness) while GLP-1 medications add injection-related and gastric emptying effects.

Route of Administration

Contrave: Oral tablets, taken twice daily. For patients who strongly prefer pills over injections, this is a meaningful advantage.

GLP-1 medications: Weekly subcutaneous injection. Some patients find this more convenient (one injection per week versus remembering pills twice daily), while others dislike needles.

Cost

Contrave: List price approximately $300-400/month. Generic versions (naltrexone + bupropion prescribed separately) can be significantly less expensive — sometimes under $50/month, since both components are available as generics.

GLP-1 medications: List price $800-1,300/month for brand-name products. Insurance coverage is variable and often requires prior authorization. The cost gap between Contrave (especially generic components) and brand-name GLP-1 medications is substantial.

When Contrave Might Be the Better Choice

Contrave isn't inferior across the board — it has genuine advantages for specific patient profiles:

Patients with concurrent depression. Bupropion is an effective antidepressant. If you have both obesity and depression, Contrave addresses both conditions simultaneously. GLP-1 medications don't have established antidepressant effects.

Patients who want to quit smoking. Bupropion (as Zyban) is FDA-approved for smoking cessation. If weight management and smoking cessation are both goals, Contrave can contribute to both.

Patients with alcohol use concerns. Naltrexone reduces alcohol cravings and consumption. If excess alcohol intake contributes to your weight management challenges, Contrave's naltrexone component addresses this directly.

Patients who refuse injections. Some people will not accept injectable medications regardless of efficacy advantages. An effective oral option is better than an injectable option that the patient won't take.

Cost-constrained patients. When GLP-1 medications are unaffordable or uncovered by insurance, generic naltrexone + bupropion offers a pharmacologically active alternative at a fraction of the cost.

Patients who don't tolerate GLP-1 medications. GI side effects from GLP-1 medications cause approximately 4-7% of patients to discontinue. For these patients, switching to a different mechanism of action may be successful.

When GLP-1 Medications Are Clearly Better

When maximum weight loss is needed. If you need to lose 15-20%+ of your body weight for health reasons — severe obesity, weight-related comorbidities that require substantial improvement, preparation for surgery — GLP-1 medications produce meaningfully more weight loss.

When metabolic improvements beyond weight are important. GLP-1 medications have demonstrated cardiovascular, renal, and hepatic benefits that Contrave has not. The SELECT trial data for semaglutide is a significant differentiator.

When insulin resistance or type 2 diabetes is present. GLP-1 medications directly improve glycemic control. Contrave does not have significant blood sugar effects.

When GI tolerance is limiting. Some patients tolerate GLP-1 GI effects better than Contrave's, and vice versa. Individual response varies.

Contraindications and Safety Considerations

Contrave Should NOT Be Used If You Have:

• Uncontrolled hypertension (bupropion can raise blood pressure)
• Seizure disorder or history of seizures (bupropion lowers the seizure threshold)
• Eating disorders (bulimia or anorexia nervosa)
• Chronic opioid use (naltrexone blocks opioid effects and can precipitate withdrawal)
• Current use of MAO inhibitors
• Abrupt discontinuation of alcohol, benzodiazepines, or barbiturates

GLP-1 Medications Should NOT Be Used If You Have:

• Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• History of pancreatitis (relative contraindication)
• Severe gastroparesis
• Pregnancy or planning pregnancy within 2 months

Can You Combine Them?

There is limited data on combining Contrave with GLP-1 medications. In theory, the different mechanisms of action could be complementary — one working through dopamine/opioid pathways and the other through incretin/GLP-1 pathways. Some obesity specialists do combine them in practice, particularly when a patient plateaus on one medication alone.

However, this is off-label combination use. The GI side effects could compound, and careful monitoring is important. This decision should be made by your provider based on your individual risk-benefit profile.

Making the Decision

The right medication depends on the right context. At CORAL, Dr. Kim evaluates each patient's complete picture — weight loss goals, medical history, concurrent conditions, medication tolerance, insurance coverage, and personal preferences — before recommending a specific approach.

There's no universal "best" weight loss medication. There's only the best one for your situation.

---

Want to understand which weight loss medication approach fits your goals, health profile, and budget? A personalized evaluation sorts through the options so you don't have to guess. [Start your evaluation at coral.clinic/start](https://coral.clinic/start).